WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2024 Issue has been successfully launched on 1 OCTOBER 2024.

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • IFSIJ Measure of Journal Quality
  • Scientific Journal Impact Factor (SJIF)
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database

Abstract

THERAPEUTIC EVALUATION OF BADRANJBOYA (MELISSA OFFICINALIS) IN FASADE TASHAHHUM FID DAM (DYSLIPIDAEMIA) IN COMPARISON TO ATORVASTATIN- A RESEARCH ARTICLE

Dr. Mohammad Danish*, Dr. Swaleha Khan, Dr. Seemab Alam, Dr. Kahkashan Baig and Dr. K. Lalitha

ABSTRACT

There is no doubt that dyslipidaemia is one of the most common risk factor of cardio vascular diseases. This vulnerable disease is essentially an abnormal concentration of lipids or lipoproteins in blood. Increased level of cholesterol is responsible for atherogenesis, which ultimately leads to development of cardiovascular, cerebro vascular and peripheral vascular diseases. This disease has a significant contribution towards mortality and morbidity rates and also poses economic downfall among patients. These days the treatment of dyslipidaemia is lipid lowering agents with life style intervention, while lipid lowering agents are producing various side effects. In Unani system of medicine several drugs are being used as lipid lowering agents, which are comparatively safe. However, such drugs are still not validated on scientific parameters. Two different drugs were selected and present study contemplated as “Therapeutic evaluation of B?dranjboya (Melissa officinalis) In Fas?de Tashahhum Fid Dam (Dyslipidaemia) In Comparison to Atorvastatin” Thus, a clinical trial was conducted with the objective of providing safe and effective drug in the management of dyslipidaemia.

[Full Text Article] [Download Certificate]